Deals

IZEA Raises $12M at 47% Discount from Special Situation Funds

By |

IZEA Inc. (IZEA) announced that it has raised $12,000,000 in a Common Stock transaction. The common stock was sold at $0.35 per share, an approximate 47% discount to the market price ($0.66) of IZEA at deal announcement. A series of 17,142,857 60-Month Warrants with an exercise price of $0.35 per share (46.97% discount) was issued to the investors in this transaction. An additional series of 17,142,857 60-Month Warrants with an exercise price of $0.50 per share (24.24% discount) was issued to the investors in this transaction. Craig-Hallum Capital Group LLC acted as the exclusive agent on the transaction.

Deals

Acasti Pharma Raises $2M at 6% Discount from Fiera Capital

By |

Acasti Pharma Inc (ACST) announced that it has raised $1,955,045 in a Units (Common Stock + Warrants) transaction. The common stock was sold at $1.21 per share, an approximate 6% discount to the market price ($1.28) of ACST at deal announcement. A series of 1,616,541 48-Month Warrants with an exercise price of $1.46 per share (13.67% premium) was issued to the investors in this transaction. Euro Pacific Canada, Inc. acted as the exclusive agent on the transaction. The investor was Fiera Capital.

Deals

Novelos Therapeutics Raises $4M in Conv Debt Deal

By |

Novelos Therapeutics, Inc. (NVLT) announced that it has raised $4,000,000 in a Convertible Debentures transaction. The fixed conversion price of the Convertible Debentures is $0.50 per share, an approximate 35.14% premium to the market price ($0.37) of NVLT at deal announcement. A series of 8,000,000 60-Month Warrants with an exercise price of $1.00 per share was issued to the investors in this transaction. The transaction closed on 02/07/2014. via PlacementTracker.

Deals

Gold Standard Ventures Raises $9M to Finance Acquisition

By |

Gold Standard Ventures Corporation (GSV) announced that it has raised $9,008,334 in a Units (Common Stock + Warrants) transaction. The common stock was sold at $0.65 per share. A series of 6,944,445 24-Month Warrants with an exercise price of $0.90 per share (38.56% premium) was issued to the investors in this transaction. Macquarie Capital Markets Canada acted as the exclusive agent on the transaction. The transaction is expected to close concurrently with the acquisition of Pinion.